SS Innovations International In (SSII) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- —
- Estimate
- -$0.01
- Surprise
- —
- Score today
- 5.8/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
Coverage in the report window
- SS Innovations Showcases Robotic Telesurgery Capabilities at International Medical Conferences — fiscal.ai, 2026-10-26
Where TrendMatrix's rating stands now
TrendMatrix currently rates SSII Sell at 5.8/10; no pre/post engine snapshot brackets this report.
0 of the last 2 quarters beat the estimate.
What argues against it
- Quality below floor (2.9 < 4.0)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $2.50
- Price target
- $5.95
- Stop
- $2.33
- Upside to target
- +138.0%
- Reward-to-risk
- 9.2:1
Risk check: trading volume is running 1.7× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-10-28 — shown for context, not personalized investment advice.
SSII at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $501.2M
- P/E (fwd)
- -41.7
- 52-week range
- $2.20–$9.05
- Off 52-week high
- 72.4%
- RSI (14)
- 40
- Volume vs avg
- 1.68×
- Score today
- 5.8/10